Bulletin
Investor Alert

Arrowhead Pharmaceuticals Corp.

NAS: ARWR

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204828235/composite

$

69.00

Change

+0.68 +1.00%

Volume

Volume 4,156

Jul 29, 2021, 7:54 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204828235/composite

Today's close

$ 68.37

$ 68.32

Change

-0.05 -0.07%

Day low

Day high

$68.02

$70.97

Open
Open: 69.70

52 week low

52 week high

$32.86

$93.66

Open

Market cap

$7.12B

Average volume

953,802

P/E ratio

N/A

Rev. per Employee

$379,276

EPS

-1.07

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/arwr

MarketWatch News on ARWR

  1. Biotech M&A Has Been Slow This Year. Why It Might Get Busier.

    8:32 a.m. May 21, 2021

    - Barron's Online

  2. These 10 Stock Picks Are Up 197% Over the Past Year

    5:31 p.m. April 12, 2021

    - Barron's Online

  3. Biotech stocks are a buy — especially these 18 picks

    2:02 p.m. March 13, 2021

    - Michael Brush

  4. What fat tails have to do with retirement finance

    3:20 p.m. Dec. 4, 2020

    - Mark Hulbert

  5. Arrowhead Pharmaceuticals upgraded to outperform from perform at Oppenheimer

    8:35 a.m. May 8, 2020

    - Tomi Kilgore

  6. The top-performing stock of 2019

    3:15 p.m. Dec. 6, 2019

    - Mark Hulbert

  7. Arrowhead Stock’s Surge Will Continue, Analyst Says

    10:53 a.m. Nov. 29, 2019

    - Barron's Online

  8. Arrowhead Pharma stock price target raised to $81 at Chardan

    9:19 a.m. Nov. 29, 2019

    - Ciara Linnane

  9. Here are the stocks that have soared and sunk the most in 2019

    11:21 a.m. Oct. 2, 2019

    - Philip van Doorn

  10. How Biotech Is Targeting RNA to Cure Diseases

    8:01 a.m. Sept. 3, 2019

    - Barron's Online

  11. Arrowhead Pharmaceuticals and three other stocks to watch

    11:02 a.m. Aug. 29, 2019

    - Harry Boxer

  12. Bull trend (tenuously) intact: S&P 500 rattles the August range

    12:36 p.m. Aug. 27, 2019

    - Michael Ashbaugh

  13. Bull trend (tenuously) intact: S&P 500 rattles the August range

    12:01 p.m. Aug. 27, 2019

    - Michael Ashbaugh

  14. Arrowhead Pharmaceuticals stock price target raised to $46 from $32 at B. Riley FBR

    7:30 a.m. Aug. 19, 2019

    - Tomi Kilgore

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/arwr

Other News on ARWR

  1. FDA grants Arrowhead's ARO-AAT liver disease treatment Breakthrough Therapy status

    7:36 a.m. Today

    - Seeking Alpha

  2. 7 Best ETFs to Buy That Will Make Your World a Better Place

    12:10 p.m. July 22, 2021

    - InvestorPlace.com

  3. Arrowhead Pharmaceuticals: Buy the Dip?

    10:46 a.m. July 19, 2021

    - Motley Fool

  4. ARWR, OPTT, CTXR and ITRM among midday movers

    1:48 p.m. July 2, 2021

    - Seeking Alpha

  5. Arrowhead initiates mid-stage ARO-ANG3 mixed dyslipidemia study

    7:49 a.m. June 30, 2021

    - Seeking Alpha

  6. Arrowhead posts positive data from early-stage NASH trial

    7:38 a.m. June 23, 2021

    - Seeking Alpha

  7. Seeking Alpha Catalyst Watch

    3:30 p.m. June 18, 2021

    - Seeking Alpha

  8. Arrowhead: On Target With RNAi Innovation

    5:26 p.m. June 14, 2021

    - Seeking Alpha

  9. Loading more headlines...
/news/pressrelease/company/us/arwr

Press Releases on ARWR

  1. Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Third Quarter Results

    7:30 a.m. July 14, 2021

    - BusinessWire - BZX

  2. What to do After Altimmune and Arrow Pharmaceuticals Plunged

    6:57 a.m. July 7, 2021

    - Baystreet.ca

  3. Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study

    7:30 a.m. July 2, 2021

    - BusinessWire - BZX

  4.  Arrowhead Pharmaceuticals to Participate in Upcoming Conferences

    7:30 a.m. June 2, 2021

    - BusinessWire - BZX

  5. Arrowhead Earns $10 Million Option Exercise Fee

    7:30 a.m. May 18, 2021

    - BusinessWire - BZX

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.